USP5 and monoclonal gammopathy: As shown in Figure 6a, the mRNA levels of USP5 was markedly increased in malignant plasma cells including MM, plasma cell leukemia (PCL) and smoldering myelomas (SMM), in contrast, its expression was relatively low in patients of monoclonal gammopathy of undetermined significance, the early stage of MM.